bibliographic entry 9107611 [be/9107611]
https://w3id.org/oc/corpus/be/9107611

is a

• bibliographic reference

content

• Degn, KB, Juhl, CB, Sturis, J. One week’s treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha-and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes. Diabetes 2004; 53: 1187–1194 PMID: 15111485

references

• https://w3id.org/oc/corpus/br/3491319